메뉴 건너뛰기




Volumn 18, Issue 8, 2012, Pages 426-434

Primary nonadherence to medications in an integrated healthcare setting

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIASTHMATIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; ANTIMIGRAINE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CARDIOVASCULAR AGENT;

EID: 84869237740     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (42)

References (18)
  • 1
    • 38549098101 scopus 로고    scopus 로고
    • Medication compliance and persistence: Terminology and definitions
    • Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44-47.
    • (2008) Value Health , vol.11 , Issue.1 , pp. 44-47
    • Cramer, J.A.1    Roy, A.2    Burrell, A.3
  • 2
    • 20544460816 scopus 로고    scopus 로고
    • Impact of medicationadherence on hospitalization risk and healthcare cost
    • Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medicationadherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521-530.
    • (2005) Med Care , vol.43 , Issue.6 , pp. 521-530
    • Sokol, M.C.1    McGuigan, K.A.2    Verbrugge, R.R.3    Epstein, R.S.4
  • 3
    • 23044442340 scopus 로고    scopus 로고
    • Adherence to medication
    • Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353(5):487-497.
    • (2005) N Engl J Med , vol.353 , Issue.5 , pp. 487-497
    • Osterberg, L.1    Blaschke, T.2
  • 4
    • 79951624338 scopus 로고    scopus 로고
    • Medication adherence leads to lower health care use and costs despite increased drug spending
    • Millwood
    • Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood). 2011;30(1):91-99.
    • (2011) Health Aff , vol.30 , Issue.1 , pp. 91-99
    • Roebuck, M.C.1    Liberman, J.N.2    Gemmill-Toyama, M.3    Brennan, T.A.4
  • 6
    • 77049124104 scopus 로고    scopus 로고
    • Medication nonfulfillment rates and reasons: Narrative systematic review
    • Gadkari AS, McHorney CA. Medication nonfulfillment rates and reasons: narrative systematic review. Curr Med Res Opin. 2010;26(3): 683-705.
    • (2010) Curr Med Res Opin , vol.26 , Issue.3 , pp. 683-705
    • Gadkari, A.S.1    McHorney, C.A.2
  • 7
    • 69749108431 scopus 로고    scopus 로고
    • New prescription medication gaps: A comprehensive measure of adherence to new prescriptions
    • Karter AJ, Parker MM, Moffet HH, et al. New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Serv Res. 2009;44(5, pt 1):1640-1661.
    • (2009) Health Serv Res , vol.44 , Issue.5 PART 1 , pp. 1640-1661
    • Karter, A.J.1    Parker, M.M.2    Moffet, H.H.3
  • 8
    • 84856720108 scopus 로고    scopus 로고
    • Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders
    • Raebel MA, Ellis JL, Carroll NM, et al. Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders. J Gen Intern Med. 2012;27(1):57-64.
    • (2012) J Gen Intern Med , vol.27 , Issue.1 , pp. 57-64
    • Raebel, M.A.1    Ellis, J.L.2    Carroll, N.M.3
  • 9
    • 77954713708 scopus 로고    scopus 로고
    • Determinants of primary nonadherence in asthma-controller and dyslipidemia pharmacotherapy
    • Liberman JN, Hutchins DS, Popiel RG, et al. Determinants of primary nonadherence in asthma-controller and dyslipidemia pharmacotherapy. Am J Pharm Benefits. 2010;2(2):111-118.
    • (2010) Am J Pharm Benefits , vol.2 , Issue.2 , pp. 111-118
    • Liberman, J.N.1    Hutchins, D.S.2    Popiel, R.G.3
  • 10
    • 0023092594 scopus 로고
    • A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
    • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40(5):373-383.
    • (1987) J Chron Dis , vol.40 , Issue.5 , pp. 373-383
    • Charlson, M.E.1    Pompei, P.2    Ales, K.L.3    MacKenzie, C.R.4
  • 11
    • 79959958730 scopus 로고    scopus 로고
    • A meta-analysis of osteoporotic fracture risk with medication nonadherence
    • Ross S, Samuels E, Gairy K, et al. A meta-analysis of osteoporotic fracture risk with medication nonadherence. Value Health. 2011;14(4): 571-581.
    • (2011) Value Health , vol.14 , Issue.4 , pp. 571-581
    • Ross, S.1    Samuels, E.2    Gairy, K.3
  • 12
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 highrisk individuals: A randomised placebo-controlled trial
    • Heart Protection Study Collaborative Group
    • Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 highrisk individuals: a randomised placebo-controlled trial. Lancet. 2002; 360(9326):7-22.
    • (2002) Lancet , vol.360 , Issue.9326 , pp. 7-22
  • 13
    • 79960389336 scopus 로고    scopus 로고
    • Cost-effectiveness of statin therapy for primary prevention in a lowcost statin era
    • Lazar LD, Pletcher MJ, Coxson PG, Bibbins-Domingo K, Goldman L. Cost-effectiveness of statin therapy for primary prevention in a lowcost statin era. Circulation. 2011;124(2):146-153.
    • (2011) Circulation , vol.124 , Issue.2 , pp. 146-153
    • Lazar, L.D.1    Pletcher, M.J.2    Coxson, P.G.3    Bibbins-Domingo, K.4    Goldman, L.5
  • 14
    • 80054769755 scopus 로고    scopus 로고
    • Cost-effectiveness of oral bisphosphonates for osteoporosis at different ages and levels of life expectancy
    • Pham AN, Datta SK, Weber TJ, Walter LC, Colón-Emeric CS. Cost-effectiveness of oral bisphosphonates for osteoporosis at different ages and levels of life expectancy. J Am Geriatr Soc. 2011;59(9):1642-1649.
    • (2011) J Am Geriatr Soc , vol.59 , Issue.9 , pp. 1642-1649
    • Pham, A.N.1    Datta, S.K.2    Weber, T.J.3    Walter, L.C.4    Colón-Emeric, C.S.5
  • 15
    • 33750072299 scopus 로고    scopus 로고
    • Primary medication adherence in a rural population: The role of the patient-physician relationship and satisfaction with care
    • Wroth TH, Pathman DE. Primary medication adherence in a rural population: the role of the patient-physician relationship and satisfaction with care. J Am Board Fam Med. 19(5):478-486.
    • J Am Board Fam Med , vol.19 , Issue.5 , pp. 478-486
    • Wroth, T.H.1    Pathman, D.E.2
  • 16
    • 51349156689 scopus 로고    scopus 로고
    • Unfilled prescriptions of medicare beneficiaries: Prevalence, reasons, and types of medicines prescribed
    • Kennedy J, Tuleu I, Mackay K. Unfilled prescriptions of medicare beneficiaries: prevalence, reasons, and types of medicines prescribed. J Manag Care Pharm. 2008;14(6):553-560.
    • (2008) J Manag Care Pharm , vol.14 , Issue.6 , pp. 553-560
    • Kennedy, J.1    Tuleu, I.2    Mackay, K.3
  • 17
    • 58649088220 scopus 로고    scopus 로고
    • Factors associated with first-fill adherence rates for diabetic medications: A cohort study
    • Shah NR, Hirsch AG, Zacker C, et al. Factors associated with first-fill adherence rates for diabetic medications: a cohort study. J Gen Intern Med. 2009;24(2):233-237.
    • (2009) J Gen Intern Med , vol.24 , Issue.2 , pp. 233-237
    • Shah, N.R.1    Hirsch, A.G.2    Zacker, C.3
  • 18
    • 62849103057 scopus 로고    scopus 로고
    • Predictors of first-fill adherence for patients with hypertension
    • Shah NR, Hirsch AG, Zacker C, et al. Predictors of first-fill adherence for patients with hypertension. Am J Hypertens. 2009;22(4):392-396.
    • (2009) Am J Hypertens , vol.22 , Issue.4 , pp. 392-396
    • Shah, N.R.1    Hirsch, A.G.2    Zacker, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.